Comparing effectiveness and safety of sglt2 inhibitors vs dpp-4 inhibitors in patients with type 2 diabetes and varying baseline hba1c levels

HIGHLIGHTS

  • who: American Medical Association from the (UNIVERSITY) have published the Article: Comparing Effectiveness and Safety of SGLT2 Inhibitors vs DPP-4 Inhibitors in Patients With Type 2 Diabetes and Varying Baseline HbA1c Levels, in the Journal: (JOURNAL)

SUMMARY

    @@

ACRONYMS

LAY DEFINITIONS

  • DPP-4: Dipeptidyl peptidase-4 (DPP4), also known as adenosine deaminase complexing protein 2 or CD26 (cluster of differentiation 26) is a protein that, in humans, is encoded by the DPP4 gene. DPP4 is related to FAP, DPP8, and DPP9
  • Safety: Freedom from exposure . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?